Vizient, Inc.

From EverybodyWiki Bios & Wiki



Vizient, Inc.
ISIN🆔
IndustryHealth care
Founded 📆
Founder 👔
Headquarters 🏙️,
Irving, Texas
,
Area served 🗺️
Key people
Byron Jobe[1] (CEO)
Members
Number of employees
3,100 (2019[2])
🌐 Websitewww.vizientinc.com
📇 Address
📞 telephone

Vizient, Inc.[3] is a health care performance improvement company and group purchasing organization[4] headquartered in Irving, Texas. It provides health care analytics, supply chain, research[5], advisory and advocacy[6] services to the health care industry including 95% of U.S. academic medical centers[7].

History[edit]

Originally founded in 1977, the Vizient brand was formed in January 2016 after the merger of VHA, Inc, University HealthSystem Consortium (UHC) and Novation in 2015.[8] In 2016, Vizient acquired the MedAssets’ Spend and Clinical Resource Management (SCM) segment and the Sg2 company.[9]

Health care advocacy and communication[edit]

Vizient advocacy and communications have related to U.S. health care topics:

  • Pharmaceutical spending[10], national drug shortages[11], biosimilars[12]
  • Health care policy[5]  
  • Patient safety initiatives[13] including opioid crisis[14], hospital quality measures[15], cybersecurity[16]

References[edit]

  1. "Vizient About Us Careers". Retrieved 2019-04-25.
  2. "2018 100 Most Influential People in Healthcare". Retrieved 2019-06-03.
  3. "Bloomberg Snapshot". Bloomberg. Retrieved 2019-06-03.
  4. "4 of the largest GPOs I 2017". Becker's Hospital Review. 2017-02-06. Retrieved 2019-06-02.
  5. 5.0 5.1 "Health policy changes could affect reimbursement: What to know". Managed Heatlhcare Executive. 2017-12-02. Retrieved 2019-06-03.
  6. "FDA Hears From Stakeholders About Insulin Transition to Biologic Pathway in 2020". The Center for Biosimilars. 2019-05-14. Retrieved 2019-06-03.
  7. "Vizient Clinical Data Base Chosen by More Than 60 New Hospitals in 2017 for Quality Improvement Initiatives | Newsroom – Vizient". newsroom.vizientinc.com. Retrieved 2019-06-04.
  8. "VHA-UHC Alliance to be called Vizient". Modern Healthcare. 2015-11-19. Retrieved 2019-04-25.
  9. "$2.7 billion MedAssets sale shakes up healthcare group-purchasing market". Modern Healthcare. 2015-11-02. Retrieved 2019-04-25.
  10. "Vizient Sees 4.28% Increase in Health System Pharmaceutical Spending". AJMC. 2019-01-19.
  11. "U.S. Hospitals Wrestle With Shortages of Drug Supplies Made in Puerto Rico". The New York Times. 2017-10-23.
  12. "Drug Pricing Forecast Reminds Stakeholders About Role of Biosimilars". The Center for Biosimilars. 2019-02-01.
  13. "Congressional Briefing Highlights Importance and Benefits of Engaging Patients Throughout Continuum of Care". Healthcare Leadership Council. 2019-02-23.
  14. "Doctors: If You Aren't Part of the Opioid Crisis Solution, You're Part of the Problem". U.S. News & World Report. 2018-12-17.
  15. "Hospitals hopeful big changes are coming to the CMS' star ratings". Modern Healthcare. 2019-05-02.
  16. "What Government Organizations Can Learn From The Private Sector About Cybersecurity". Forbes. 2018-08-29.

External links[edit]


This article "Vizient, Inc" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Vizient, Inc. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.